Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Travis

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The Cochrane Database of Systematic Reviews|September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitisVipul Jairath, G Y Zou, Claire E Parker, et al.
World Journal of Gastroenterology|September 3, 2020
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and OxfordSamba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, et al.
The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2016
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cellsHannah H Chen, Norman Händel, Joanne Ngeow, et al.
Health Technology Assessment (Winchester, England)|August 22, 2019
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy studyStuart A Taylor, Sue Mallett, Gauraang Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2018
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialStuart A Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
JAMA|December 17, 2015
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical TrialChristopher J Hawkey, Matthieu Allez, Miranda M Clark, et al.
Journal of Medical Internet Research|September 3, 2024
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort StudiesSarah M Goodday, Emma Karlin, Alexa Brooks, et al.
European Radiology|May 14, 2025
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohortStuart A Taylor, Shankar Kumar, Thomas Parry, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The Cochrane Database of Systematic Reviews|September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitisVipul Jairath, G Y Zou, Claire E Parker, et al.
World Journal of Gastroenterology|September 3, 2020
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and OxfordSamba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, et al.
The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2016
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cellsHannah H Chen, Norman Händel, Joanne Ngeow, et al.
Health Technology Assessment (Winchester, England)|August 22, 2019
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy studyStuart A Taylor, Sue Mallett, Gauraang Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2018
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialStuart A Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
JAMA|December 17, 2015
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical TrialChristopher J Hawkey, Matthieu Allez, Miranda M Clark, et al.
Journal of Medical Internet Research|September 3, 2024
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort StudiesSarah M Goodday, Emma Karlin, Alexa Brooks, et al.
European Radiology|May 14, 2025
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohortStuart A Taylor, Shankar Kumar, Thomas Parry, et al.
Pageof 17